Blackstone’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$843K Buy
+14,444
New +$852K ﹤0.01% 246
2020
Q4
– Sell
-363,589
Closed -$15.3M – 267
2020
Q3
$15.3M Buy
363,589
+308,589
+561% +$13.2M 0.06% 77
2020
Q2
$2.67M Buy
+55,000
New +$2.72M 0.01% 119

Other funds holding RPRX

Blackstone's RPRX Position: Q3 2026 in Review

Blackstone opened a new position in Royalty Pharma (RPRX) in Q3 2026: 14,444 shares worth $843K. The stake represents ﹤0.01% of the portfolio and ranks #246 among its holdings. This is a return to the name: Blackstone previously reported a position in RPRX as recently as Q3 2020.

Blackstone first reported a position in RPRX in Q2 2020 and has held it in 3 quarters since. The position peaked at $15.3M in Q3 2020. 697 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Blackstone held 14,444 shares of Royalty Pharma worth $843K as of Q3 2026.
  • Royalty Pharma was a new Blackstone position in Q3 2026.
  • Royalty Pharma made up ﹤0.01% of Blackstone's portfolio in Q3 2026, its #246 holding.
  • Blackstone first reported a position in Royalty Pharma in Q2 2020 and has held it in 3 quarters since.
  • Blackstone's Royalty Pharma position peaked at $15.3M in Q3 2020.
  • 697 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.